CD8A and neoplasm: Overexpression of miR-4458 inhibits tumor growth, decreases the proportion of PD-1+ T cells and the expression of PD-L1 and IL-10, and upregulates the proportion of CD4+ T and CD8+ T cells as well as the expression of IFN-γ and IL-2 [14].